Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether a drug named Fluvastatin is beneficial and safe in reducing the risk of cardiovascular disease and blood clots in patients with antiphospholipid antib...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospital for Special Surgery, New York
Collaborators
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT07372170 · Antiphospholipid Syndrome (APS), Venous Thrombosis (Disorder), and more
NCT00616317 · Antiphospholipid Syndrome
NCT06373926 · Antiphospholipid Syndrome
NCT06828042 · Systemic Lupus Erthematosus, Systemic Sclerosis (SSc), and more
Hospital for Special Surgery
New York, New York
Division of Rheumatology, University of Texas Medical Branch
Galveston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions